SHAREHOLDER NOTICE: Goldberg Law PC Announces Securities Class Action Lawsuit Against CTI BioPharma Corp. And Encourages Inve...
February 11 2016 - 4:03PM
Business Wire
Goldberg Law PC (www.Goldberglawpc.com) announces that a class
action lawsuit has been filed against CTI BioPharma Corp. (“CTI” or
the “Company”) (Nasdaq: CTIC). Investors who purchased or otherwise
acquired shares between March 4, 2014 and February 9, 2016, (the
“Class Period”), are encouraged to contact the firm no later than
60 days from the date of this notice.
If you are a shareholder who suffered a loss during the Class
Period, we advise you to contact Michael Goldberg or Brian Schall,
of Goldberg Law PC, 13650 Marina Pointe Dr. Suite 708, Marina Del
Rey, CA 90292, at 800-977-7401, to discuss your rights without cost
to you. You can also reach us through the firm’s website at
http://www.Goldberglawpc.com, or by email at
info@goldberglawpc.com.
The class in this case has not yet been certified, and until
certification occurs, you are not represented by an attorney. If
you choose to take no action, you can remain an absent class
member.
According to the complaint, the Company failed to disclose that:
(1) CTI’s clinical trials showed that patient deaths were related
to pacritinib usage; (2) CTI’s application for the approval of
pacritinib would likely be withdrawn; (3) the Company’s future
revenues were impaired; and (4) that the company lacked adequate
internal controls.
Goldberg Law PC represents shareholders around the world and
specializes in securities class actions and shareholder rights
litigation.
This press release may be considered Attorney Advertising in
some jurisdictions under the applicable law and ethical rules.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160211006439/en/
Goldberg Law PC, Los AngelesMichael Goldberg, Esq.,
800-977-7401Brian Schall, Esq.,
800-977-7401info@goldberglawpc.com
CTI BioPharma (NASDAQ:CTIC)
Historical Stock Chart
From Mar 2024 to Apr 2024
CTI BioPharma (NASDAQ:CTIC)
Historical Stock Chart
From Apr 2023 to Apr 2024